These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 33552662)

  • 21. Spontaneous Tumor Lysis Syndrome in Small Cell Lung Cancer.
    Kanchustambham V; Saladi S; Patolia S; Stoeckel D
    Cureus; 2017 Feb; 9(2):e1017. PubMed ID: 28344911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effectiveness of Single-dose Rasburicase in Patients With Lymphoid Malignancies at a High Risk for Tumor Lysis Syndrome.
    Jeon YW; Kwak DH; Park SS; Yoon JH; Lee SE; Eom KS; Kim YJ; Kim HJ; Lee S; Min CK; Lee JW; Min WS; Cho SG
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):595-603. PubMed ID: 28711571
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Managing Tumor Lysis Syndrome in the Era of Novel Cancer Therapies.
    McBride A; Trifilio S; Baxter N; Gregory TK; Howard SC
    J Adv Pract Oncol; 2017; 8(7):705-720. PubMed ID: 30333933
    [No Abstract]   [Full Text] [Related]  

  • 24. Rasburicase for the management of tumor lysis syndrome in neonates.
    McNutt DM; Holdsworth MT; Wong C; Hanrahan JD; Winter SS
    Ann Pharmacother; 2006; 40(7-8):1445-50. PubMed ID: 16868218
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Real-world outcomes and management strategies for venetoclax-treated chronic lymphocytic leukemia patients in the United States.
    Mato AR; Thompson M; Allan JN; Brander DM; Pagel JM; Ujjani CS; Hill BT; Lamanna N; Lansigan F; Jacobs R; Shadman M; Skarbnik AP; Pu JJ; Barr PM; Sehgal AR; Cheson BD; Zent CS; Tuncer HH; Schuster SJ; Pickens PV; Shah NN; Goy A; Winter AM; Garcia C; Kennard K; Isaac K; Dorsey C; Gashonia LM; Singavi AK; Roeker LE; Zelenetz A; Williams A; Howlett C; Weissbrot H; Ali N; Khajavian S; Sitlinger A; Tranchito E; Rhodes J; Felsenfeld J; Bailey N; Patel B; Burns TF; Yacur M; Malhotra M; Svoboda J; Furman RR; Nabhan C
    Haematologica; 2018 Sep; 103(9):1511-1517. PubMed ID: 29880613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Needle in the Haystack: A Rare Case of Spontaneous Tumor Lysis in Newly Diagnosed Chronic Lymphocytic Leukemia Unmasked by Acute Renal Failure.
    Desai M; Parsi M; Potdar R; Sanjay R
    Cureus; 2020 Oct; 12(10):e11279. PubMed ID: 33274154
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Acute tumor lysis syndrome and treatment response in patients treated for refractory chronic lymphocytic leukemia with short-course, high-dose cytosine arabinoside, cisplatin, and etoposide.
    McCroskey RD; Mosher DF; Spencer CD; Prendergast E; Longo WL
    Cancer; 1990 Jul; 66(2):246-50. PubMed ID: 2369709
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Venetoclax for the treatment of patients with chronic lymphocytic leukemia.
    Crombie J; Davids MS
    Future Oncol; 2017 Jun; 13(14):1223-1232. PubMed ID: 28492339
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor Lysis Syndrome.
    Williams SM; Killeen AA
    Arch Pathol Lab Med; 2019 Mar; 143(3):386-393. PubMed ID: 30499695
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor Lysis Syndrome Caused by Unrecognized Richter's Transformation of Chronic Lymphocytic Leukemia: Treatment With Venetoclax for Suspected Disease Progression.
    Chango Azanza JJ; Calle Sarmiento PM; Mathew Thomas V; Lopetegui Lia N; Kidwai N
    Cureus; 2020 May; 12(5):e8145. PubMed ID: 32550064
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pediatric considerations in tumor lysis syndrome.
    Truini-Pittman L; Rossetto C
    Semin Oncol Nurs; 2002 Aug; 18(3 Suppl 3):17-22. PubMed ID: 12184048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Approaches to Managing Safety With Lenalidomide in Hematologic Malignancies.
    Blumel S; Broadway-Duren J
    J Adv Pract Oncol; 2014; 5(4):269-79. PubMed ID: 26110071
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A predictive model for the detection of tumor lysis syndrome during AML induction therapy.
    Mato AR; Riccio BE; Qin L; Heitjan DF; Carroll M; Loren A; Porter DL; Perl A; Stadtmauer E; Tsai D; Gewirtz A; Luger SM
    Leuk Lymphoma; 2006 May; 47(5):877-83. PubMed ID: 16753873
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protocols for managing chemotherapy-induced neutropenia in clinical oncology practices.
    White N; Maxwell C; Michelson J; Bedell C
    Cancer Nurs; 2005; 28(1):62-9. PubMed ID: 15681984
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A Retrospective Review of Tumor Lysis Syndrome Associated With Colorectal Cancer.
    Ansari Z; Findakly D; Wang J
    Cureus; 2020 May; 12(5):e8257. PubMed ID: 32596075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of tumor lysis syndrome: prevention and treatment.
    Gobel BH
    Semin Oncol Nurs; 2002 Aug; 18(3 Suppl 3):12-6. PubMed ID: 12184047
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of tumor lysis syndrome in patients with multiple myeloma during bortezomib treatment.
    Wang L; Jian Y; Yang G; Gao W; Wu Y; Zuo L
    Clin J Oncol Nurs; 2015 Feb; 19(1):E4-7. PubMed ID: 25689664
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Final results of a multicenter phase 1 study of lenalidomide in patients with relapsed or refractory chronic lymphocytic leukemia.
    Wendtner CM; Hillmen P; Mahadevan D; Bühler A; Uharek L; Coutré S; Frankfurt O; Bloor A; Bosch F; Furman RR; Kimby E; Gribben JG; Gobbi M; Dreisbach L; Hurd DD; Sekeres MA; Ferrajoli A; Shah S; Zhang J; Moutouh-de Parseval L; Hallek M; Heerema NA; Stilgenbauer S; Chanan-Khan AA
    Leuk Lymphoma; 2012 Mar; 53(3):417-23. PubMed ID: 21879809
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Acute tumor lysis syndrome induced by high-dose corticosteroids in a patient with chronic lymphatic leukemia.
    Vaisban E; Zaina A; Braester A; Manaster J; Horn Y
    Ann Hematol; 2001 May; 80(5):314-5. PubMed ID: 11446738
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumour lysis syndrome: new therapeutic strategies and classification.
    Cairo MS; Bishop M
    Br J Haematol; 2004 Oct; 127(1):3-11. PubMed ID: 15384972
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.